Skip to main content
RHYTHM PHARMACEUTICALS, INC. logo

RHYTHM PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · RYTM ISIN · US76243J1051 LEI · 529900JPNWXQ8DPLA551 US Manufacturing
Open in API
Filings indexed 775 across all filing types
Latest filing 2019-01-18 Director's Dealing
Country US United States of America
Listing US RYTM

About RHYTHM PHARMACEUTICALS, INC.

https://rhythmtx.com/

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on developing and commercializing precision medicines for rare genetic diseases of obesity. The company's work centers on the melanocortin-4 receptor (MC4R) pathway, a key biological system that regulates hunger and energy expenditure. Its lead product, IMCIVREE® (setmelanotide), is an MC4R agonist approved for treating severe obesity and hyperphagia (insatiable hunger) in patients with specific rare conditions, such as Bardet-Biedl syndrome. Rhythm is dedicated to advancing a portfolio of therapies that address the root cause of rare neuroendocrine diseases to improve patient outcomes.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2019-01-18 English
4
Director's Dealing
2019-01-17 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 4, 2019, by Rhythm Pharmaceuticals, Inc. It reports Regulation FD Disclosure about updated clinical data and expected 2019 milestones to be presented at an upcoming healthcare conference. The document includes a press release and presentation slides as exhibits. There are no financial statements or detailed financial data included in the text. The document is a current report announcing information rather than a full financial report or earnings release. Given the nature of the content and the format, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2019-01-07 English
4
Director's Dealing
2018-12-06 English
S-3ASR
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 registration statement filed with the SEC by Rhythm Pharmaceuticals, Inc. It is a registration statement under the Securities Act of 1933 used for registering securities for sale to the public. The text includes details about the types of securities to be registered (common stock, preferred stock, debt securities, warrants, units), the registration fee calculation, and the prospectus summary. It is not a financial report, earnings release, or management discussion. It is a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement of a report, so it is not RPA or RNS.
2018-11-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 9, 2018, by Rhythm Pharmaceuticals, Inc. It discusses the adoption of Accounting Standards Update (ASU) 2016-18 related to the statement of cash flows and restricted cash. The filing specifically states it is required to recast certain financial information included in the company's Annual Report on Form 10-K for the year ended December 31, 2017. It clarifies that this Form 8-K is being filed only for the purpose of these updates and that the original 10-K should be read in conjunction with this filing. The document includes revised Management's Discussion and Analysis and Consolidated Financial Statements as exhibits. This indicates the filing is an update or amendment to previously filed financial statements and MD&A, not the full Annual Report itself. Given the nature of the filing (a current report updating financial information and restating prior financials), the appropriate classification is Regulatory Filings (RNS), as it does not constitute a full Annual Report (10-K) but rather a regulatory update and amendment to prior filings.
2018-11-09 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.